The pathophysiological significance of the FER-PKCδ-PTPN14–mediated pathway we have identified is highlighted by our finding that high levels of pY374-PKCδ correlate with high levels of the RAB5-RAB7 transitional phenotype in triple-negative and HER2+ breast cancers. Here, PRKCD is linked to breast cancer.